img

Global PECAM-1 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global PECAM-1 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

PECAM-1 Antibody report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PECAM-1 Antibody market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Laboratory and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for PECAM-1 Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, PECAM-1 Antibody key manufacturers include Thermo Fisher, MilliporeSigma, Abcam, BioLegend, Novus Biologicals, Dianova, Santa Cruz Biotechnology, Proteintech Group and R&D Systems, etc. Thermo Fisher, MilliporeSigma, Abcam are top 3 players and held % sales share in total in 2022.
PECAM-1 Antibody can be divided into Mouse, Rabbit and Others,, etc. Mouse is the mainstream product in the market, accounting for % sales share globally in 2022.
PECAM-1 Antibody is widely used in various fields, such as Laboratory, Hospital and Others,, etc. Laboratory provides greatest supports to the PECAM-1 Antibody industry development. In 2022, global % sales of PECAM-1 Antibody went into Laboratory filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PECAM-1 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Thermo Fisher
MilliporeSigma
Abcam
BioLegend
Novus Biologicals
Dianova
Santa Cruz Biotechnology
Proteintech Group
R&D Systems
Miltenyi Biotec
Bio-Rad
LifeSpan Biosciences
Abnova
OriGene
SICGEN
YO Proteins
Enzo Life Sciences
Boster
Abeomics
Rockland Immunochemicals
Bon Opus Biosciences
Creative Biomart
US Biological
Segment by Type
Mouse
Rabbit
Others

Segment by Application


Laboratory
Hospital
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the PECAM-1 Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PECAM-1 Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PECAM-1 Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PECAM-1 Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PECAM-1 Antibody introduction, etc. PECAM-1 Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of PECAM-1 Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 PECAM-1 Antibody Market Overview
1.1 PECAM-1 Antibody Product Overview
1.2 PECAM-1 Antibody Market Segment by Type
1.2.1 Mouse
1.2.2 Rabbit
1.2.3 Others
1.3 Global PECAM-1 Antibody Market Size by Type
1.3.1 Global PECAM-1 Antibody Market Size Overview by Type (2018-2034)
1.3.2 Global PECAM-1 Antibody Historic Market Size Review by Type (2018-2024)
1.3.3 Global PECAM-1 Antibody Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PECAM-1 Antibody Sales Breakdown by Type (2018-2024)
1.4.2 Europe PECAM-1 Antibody Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific PECAM-1 Antibody Sales Breakdown by Type (2018-2024)
1.4.4 Latin America PECAM-1 Antibody Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa PECAM-1 Antibody Sales Breakdown by Type (2018-2024)
2 Global PECAM-1 Antibody Market Competition by Company
2.1 Global Top Players by PECAM-1 Antibody Sales (2018-2024)
2.2 Global Top Players by PECAM-1 Antibody Revenue (2018-2024)
2.3 Global Top Players by PECAM-1 Antibody Price (2018-2024)
2.4 Global Top Manufacturers PECAM-1 Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 PECAM-1 Antibody Market Competitive Situation and Trends
2.5.1 PECAM-1 Antibody Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PECAM-1 Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PECAM-1 Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into PECAM-1 Antibody Market
2.8 Key Manufacturers PECAM-1 Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PECAM-1 Antibody Status and Outlook by Region
3.1 Global PECAM-1 Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global PECAM-1 Antibody Historic Market Size by Region
3.2.1 Global PECAM-1 Antibody Sales in Volume by Region (2018-2024)
3.2.2 Global PECAM-1 Antibody Sales in Value by Region (2018-2024)
3.2.3 Global PECAM-1 Antibody Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global PECAM-1 Antibody Forecasted Market Size by Region
3.3.1 Global PECAM-1 Antibody Sales in Volume by Region (2024-2034)
3.3.2 Global PECAM-1 Antibody Sales in Value by Region (2024-2034)
3.3.3 Global PECAM-1 Antibody Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global PECAM-1 Antibody by Application
4.1 PECAM-1 Antibody Market Segment by Application
4.1.1 Laboratory
4.1.2 Hospital
4.1.3 Others
4.2 Global PECAM-1 Antibody Market Size by Application
4.2.1 Global PECAM-1 Antibody Market Size Overview by Application (2018-2034)
4.2.2 Global PECAM-1 Antibody Historic Market Size Review by Application (2018-2024)
4.2.3 Global PECAM-1 Antibody Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PECAM-1 Antibody Sales Breakdown by Application (2018-2024)
4.3.2 Europe PECAM-1 Antibody Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific PECAM-1 Antibody Sales Breakdown by Application (2018-2024)
4.3.4 Latin America PECAM-1 Antibody Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa PECAM-1 Antibody Sales Breakdown by Application (2018-2024)
5 North America PECAM-1 Antibody by Country
5.1 North America PECAM-1 Antibody Historic Market Size by Country
5.1.1 North America PECAM-1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America PECAM-1 Antibody Sales in Volume by Country (2018-2024)
5.1.3 North America PECAM-1 Antibody Sales in Value by Country (2018-2024)
5.2 North America PECAM-1 Antibody Forecasted Market Size by Country
5.2.1 North America PECAM-1 Antibody Sales in Volume by Country (2024-2034)
5.2.2 North America PECAM-1 Antibody Sales in Value by Country (2024-2034)
6 Europe PECAM-1 Antibody by Country
6.1 Europe PECAM-1 Antibody Historic Market Size by Country
6.1.1 Europe PECAM-1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe PECAM-1 Antibody Sales in Volume by Country (2018-2024)
6.1.3 Europe PECAM-1 Antibody Sales in Value by Country (2018-2024)
6.2 Europe PECAM-1 Antibody Forecasted Market Size by Country
6.2.1 Europe PECAM-1 Antibody Sales in Volume by Country (2024-2034)
6.2.2 Europe PECAM-1 Antibody Sales in Value by Country (2024-2034)
7 Asia-Pacific PECAM-1 Antibody by Region
7.1 Asia-Pacific PECAM-1 Antibody Historic Market Size by Region
7.1.1 Asia-Pacific PECAM-1 Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific PECAM-1 Antibody Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific PECAM-1 Antibody Sales in Value by Region (2018-2024)
7.2 Asia-Pacific PECAM-1 Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific PECAM-1 Antibody Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific PECAM-1 Antibody Sales in Value by Region (2024-2034)
8 Latin America PECAM-1 Antibody by Country
8.1 Latin America PECAM-1 Antibody Historic Market Size by Country
8.1.1 Latin America PECAM-1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America PECAM-1 Antibody Sales in Volume by Country (2018-2024)
8.1.3 Latin America PECAM-1 Antibody Sales in Value by Country (2018-2024)
8.2 Latin America PECAM-1 Antibody Forecasted Market Size by Country
8.2.1 Latin America PECAM-1 Antibody Sales in Volume by Country (2024-2034)
8.2.2 Latin America PECAM-1 Antibody Sales in Value by Country (2024-2034)
9 Middle East and Africa PECAM-1 Antibody by Country
9.1 Middle East and Africa PECAM-1 Antibody Historic Market Size by Country
9.1.1 Middle East and Africa PECAM-1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa PECAM-1 Antibody Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa PECAM-1 Antibody Sales in Value by Country (2018-2024)
9.2 Middle East and Africa PECAM-1 Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa PECAM-1 Antibody Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa PECAM-1 Antibody Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Thermo Fisher
10.1.1 Thermo Fisher Company Information
10.1.2 Thermo Fisher Introduction and Business Overview
10.1.3 Thermo Fisher PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Thermo Fisher PECAM-1 Antibody Products Offered
10.1.5 Thermo Fisher Recent Development
10.2 MilliporeSigma
10.2.1 MilliporeSigma Company Information
10.2.2 MilliporeSigma Introduction and Business Overview
10.2.3 MilliporeSigma PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.2.4 MilliporeSigma PECAM-1 Antibody Products Offered
10.2.5 MilliporeSigma Recent Development
10.3 Abcam
10.3.1 Abcam Company Information
10.3.2 Abcam Introduction and Business Overview
10.3.3 Abcam PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Abcam PECAM-1 Antibody Products Offered
10.3.5 Abcam Recent Development
10.4 BioLegend
10.4.1 BioLegend Company Information
10.4.2 BioLegend Introduction and Business Overview
10.4.3 BioLegend PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.4.4 BioLegend PECAM-1 Antibody Products Offered
10.4.5 BioLegend Recent Development
10.5 Novus Biologicals
10.5.1 Novus Biologicals Company Information
10.5.2 Novus Biologicals Introduction and Business Overview
10.5.3 Novus Biologicals PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novus Biologicals PECAM-1 Antibody Products Offered
10.5.5 Novus Biologicals Recent Development
10.6 Dianova
10.6.1 Dianova Company Information
10.6.2 Dianova Introduction and Business Overview
10.6.3 Dianova PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Dianova PECAM-1 Antibody Products Offered
10.6.5 Dianova Recent Development
10.7 Santa Cruz Biotechnology
10.7.1 Santa Cruz Biotechnology Company Information
10.7.2 Santa Cruz Biotechnology Introduction and Business Overview
10.7.3 Santa Cruz Biotechnology PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Santa Cruz Biotechnology PECAM-1 Antibody Products Offered
10.7.5 Santa Cruz Biotechnology Recent Development
10.8 Proteintech Group
10.8.1 Proteintech Group Company Information
10.8.2 Proteintech Group Introduction and Business Overview
10.8.3 Proteintech Group PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Proteintech Group PECAM-1 Antibody Products Offered
10.8.5 Proteintech Group Recent Development
10.9 R&D Systems
10.9.1 R&D Systems Company Information
10.9.2 R&D Systems Introduction and Business Overview
10.9.3 R&D Systems PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.9.4 R&D Systems PECAM-1 Antibody Products Offered
10.9.5 R&D Systems Recent Development
10.10 Miltenyi Biotec
10.10.1 Miltenyi Biotec Company Information
10.10.2 Miltenyi Biotec Introduction and Business Overview
10.10.3 Miltenyi Biotec PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Miltenyi Biotec PECAM-1 Antibody Products Offered
10.10.5 Miltenyi Biotec Recent Development
10.11 Bio-Rad
10.11.1 Bio-Rad Company Information
10.11.2 Bio-Rad Introduction and Business Overview
10.11.3 Bio-Rad PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Bio-Rad PECAM-1 Antibody Products Offered
10.11.5 Bio-Rad Recent Development
10.12 LifeSpan Biosciences
10.12.1 LifeSpan Biosciences Company Information
10.12.2 LifeSpan Biosciences Introduction and Business Overview
10.12.3 LifeSpan Biosciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.12.4 LifeSpan Biosciences PECAM-1 Antibody Products Offered
10.12.5 LifeSpan Biosciences Recent Development
10.13 Abnova
10.13.1 Abnova Company Information
10.13.2 Abnova Introduction and Business Overview
10.13.3 Abnova PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Abnova PECAM-1 Antibody Products Offered
10.13.5 Abnova Recent Development
10.14 OriGene
10.14.1 OriGene Company Information
10.14.2 OriGene Introduction and Business Overview
10.14.3 OriGene PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.14.4 OriGene PECAM-1 Antibody Products Offered
10.14.5 OriGene Recent Development
10.15 SICGEN
10.15.1 SICGEN Company Information
10.15.2 SICGEN Introduction and Business Overview
10.15.3 SICGEN PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.15.4 SICGEN PECAM-1 Antibody Products Offered
10.15.5 SICGEN Recent Development
10.16 YO Proteins
10.16.1 YO Proteins Company Information
10.16.2 YO Proteins Introduction and Business Overview
10.16.3 YO Proteins PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.16.4 YO Proteins PECAM-1 Antibody Products Offered
10.16.5 YO Proteins Recent Development
10.17 Enzo Life Sciences
10.17.1 Enzo Life Sciences Company Information
10.17.2 Enzo Life Sciences Introduction and Business Overview
10.17.3 Enzo Life Sciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Enzo Life Sciences PECAM-1 Antibody Products Offered
10.17.5 Enzo Life Sciences Recent Development
10.18 Boster
10.18.1 Boster Company Information
10.18.2 Boster Introduction and Business Overview
10.18.3 Boster PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Boster PECAM-1 Antibody Products Offered
10.18.5 Boster Recent Development
10.19 Abeomics
10.19.1 Abeomics Company Information
10.19.2 Abeomics Introduction and Business Overview
10.19.3 Abeomics PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Abeomics PECAM-1 Antibody Products Offered
10.19.5 Abeomics Recent Development
10.20 Rockland Immunochemicals
10.20.1 Rockland Immunochemicals Company Information
10.20.2 Rockland Immunochemicals Introduction and Business Overview
10.20.3 Rockland Immunochemicals PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Rockland Immunochemicals PECAM-1 Antibody Products Offered
10.20.5 Rockland Immunochemicals Recent Development
10.21 Bon Opus Biosciences
10.21.1 Bon Opus Biosciences Company Information
10.21.2 Bon Opus Biosciences Introduction and Business Overview
10.21.3 Bon Opus Biosciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Bon Opus Biosciences PECAM-1 Antibody Products Offered
10.21.5 Bon Opus Biosciences Recent Development
10.22 Creative Biomart
10.22.1 Creative Biomart Company Information
10.22.2 Creative Biomart Introduction and Business Overview
10.22.3 Creative Biomart PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Creative Biomart PECAM-1 Antibody Products Offered
10.22.5 Creative Biomart Recent Development
10.23 US Biological
10.23.1 US Biological Company Information
10.23.2 US Biological Introduction and Business Overview
10.23.3 US Biological PECAM-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
10.23.4 US Biological PECAM-1 Antibody Products Offered
10.23.5 US Biological Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PECAM-1 Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PECAM-1 Antibody Industrial Chain Analysis
11.4 PECAM-1 Antibody Market Dynamics
11.4.1 PECAM-1 Antibody Industry Trends
11.4.2 PECAM-1 Antibody Market Drivers
11.4.3 PECAM-1 Antibody Market Challenges
11.4.4 PECAM-1 Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PECAM-1 Antibody Distributors
12.3 PECAM-1 Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Mouse
Table 2. Major Company of Rabbit
Table 3. Major Company of Others
Table 4. Global PECAM-1 Antibody Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global PECAM-1 Antibody Sales by Type (2018-2024) & (Kg)
Table 6. Global PECAM-1 Antibody Sales Market Share in Volume by Type (2018-2024)
Table 7. Global PECAM-1 Antibody Sales by Type (2018-2024) & (US& Million)
Table 8. Global PECAM-1 Antibody Market Share in Value by Type (2018-2024)
Table 9. Global PECAM-1 Antibody Price by Type (2018-2024) & (USD/g)
Table 10. Global PECAM-1 Antibody Sales by Type (2024-2034) & (Kg)
Table 11. Global PECAM-1 Antibody Sales Market Share in Volume by Type (2024-2034)
Table 12. Global PECAM-1 Antibody Sales by Type (2024-2034) & (US$ Million)
Table 13. Global PECAM-1 Antibody Sales Market Share in Value by Type (2024-2034)
Table 14. Global PECAM-1 Antibody Price by Type (2024-2034) & (USD/g)
Table 15. North America PECAM-1 Antibody Sales by Type (2018-2024) & (Kg)
Table 16. North America PECAM-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe PECAM-1 Antibody Sales (Kg) by Type (2018-2024)
Table 18. Europe PECAM-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific PECAM-1 Antibody Sales (Kg) by Type (2018-2024)
Table 20. Asia-Pacific PECAM-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America PECAM-1 Antibody Sales (Kg) by Type (2018-2024)
Table 22. Latin America PECAM-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa PECAM-1 Antibody Sales (Kg) by Type (2018-2024)
Table 24. Middle East and Africa PECAM-1 Antibody Sales by Type (2018-2024) & (US$ Million)
Table 25. Global PECAM-1 Antibody Sales by Company (2018-2024) & (Kg)
Table 26. Global PECAM-1 Antibody Sales Share by Company (2018-2024)
Table 27. Global PECAM-1 Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global PECAM-1 Antibody Revenue Share by Company (2018-2024)
Table 29. Global Market PECAM-1 Antibody Price by Company (2018-2024) & (USD/g)
Table 30. Global PECAM-1 Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global PECAM-1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PECAM-1 Antibody as of 2022)
Table 33. Date of Key Manufacturers Enter into PECAM-1 Antibody Market
Table 34. Key Manufacturers PECAM-1 Antibody Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global PECAM-1 Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global PECAM-1 Antibody Sales by Region (2018-2024) & (Kg)
Table 38. Global PECAM-1 Antibody Sales Market Share in Volume by Region (2018-2024)
Table 39. Global PECAM-1 Antibody Sales by Region (2018-2024) & (US$ Million)
Table 40. Global PECAM-1 Antibody Sales Market Share in Value by Region (2018-2024)
Table 41. Global PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 42. Global PECAM-1 Antibody Sales by Region (2024-2034) & (Kg)
Table 43. Global PECAM-1 Antibody Sales Market Share in Volume by Region (2024-2034)
Table 44. Global PECAM-1 Antibody Sales by Region (2024-2034) & (US$ Million)
Table 45. Global PECAM-1 Antibody Sales Market Share in Value by Region (2024-2034)
Table 46. Global PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2024-2034)
Table 47. Global PECAM-1 Antibody Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global PECAM-1 Antibody Sales by Application (2018-2024) & (Kg)
Table 49. Global PECAM-1 Antibody Sales Market Share in Volume by Application (2018-2024)
Table 50. Global PECAM-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 51. Global PECAM-1 Antibody Sales Market Share in Value by Application (2018-2024)
Table 52. Global PECAM-1 Antibody Price by Application (2018-2024) & (USD/g)
Table 53. Global PECAM-1 Antibody Sales by Application (2024-2034) & (Kg)
Table 54. Global PECAM-1 Antibody Sales Market Share in Volume by Application (2024-2034)
Table 55. Global PECAM-1 Antibody Sales by Application (2024-2034) & (US$ Million)
Table 56. Global PECAM-1 Antibody Sales Market Share in Value by Application (2024-2034)
Table 57. Global PECAM-1 Antibody Price by Application (2024-2034) & (USD/g)
Table 58. North America PECAM-1 Antibody Sales by Application (2018-2024) (Kg)
Table 59. North America PECAM-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe PECAM-1 Antibody Sales by Application (2018-2024) (Kg)
Table 61. Europe PECAM-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific PECAM-1 Antibody Sales by Application (2018-2024) (Kg)
Table 63. Asia-Pacific PECAM-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America PECAM-1 Antibody Sales by Application (2018-2024) (Kg)
Table 65. Latin America PECAM-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa PECAM-1 Antibody Sales by Application (2018-2024) (Kg)
Table 67. Middle East and Africa PECAM-1 Antibody Sales by Application (2018-2024) & (US$ Million)
Table 68. North America PECAM-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 69. North America PECAM-1 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 70. North America PECAM-1 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 71. North America PECAM-1 Antibody Sales Market Share in Value by Country (2018-2024)
Table 72. North America PECAM-1 Antibody Sales by Country (2024-2034) & (Kg)
Table 73. North America PECAM-1 Antibody Sales Market Share in Volume by Country (2024-2034)
Table 74. North America PECAM-1 Antibody Sales by Country (2024-2034) & (US$ Million)
Table 75. North America PECAM-1 Antibody Sales Market Share in Value by Country (2024-2034)
Table 76. Europe PECAM-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 77. Europe PECAM-1 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe PECAM-1 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe PECAM-1 Antibody Sales Market Share in Value by Country (2018-2024)
Table 80. Europe PECAM-1 Antibody Sales by Country (2024-2034) & (Kg)
Table 81. Europe PECAM-1 Antibody Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe PECAM-1 Antibody Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe PECAM-1 Antibody Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific PECAM-1 Antibody Sales by Region (2018-2024) & (Kg)
Table 85. Asia-Pacific PECAM-1 Antibody Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific PECAM-1 Antibody Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific PECAM-1 Antibody Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific PECAM-1 Antibody Sales by Region (2024-2034) & (Kg)
Table 89. Asia-Pacific PECAM-1 Antibody Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific PECAM-1 Antibody Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific PECAM-1 Antibody Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America PECAM-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 93. Latin America PECAM-1 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America PECAM-1 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America PECAM-1 Antibody Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America PECAM-1 Antibody Sales by Country (2024-2034) & (Kg)
Table 97. Latin America PECAM-1 Antibody Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America PECAM-1 Antibody Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America PECAM-1 Antibody Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa PECAM-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 101. Middle East and Africa PECAM-1 Antibody Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa PECAM-1 Antibody Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa PECAM-1 Antibody Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa PECAM-1 Antibody Sales by Country (2024-2034) & (Kg)
Table 105. Middle East and Africa PECAM-1 Antibody Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa PECAM-1 Antibody Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa PECAM-1 Antibody Sales Market Share in Value by Country (2024-2034)
Table 108. Thermo Fisher Company Information
Table 109. Thermo Fisher Introduction and Business Overview
Table 110. Thermo Fisher PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 111. Thermo Fisher PECAM-1 Antibody Product
Table 112. Thermo Fisher Recent Development
Table 113. MilliporeSigma Company Information
Table 114. MilliporeSigma Introduction and Business Overview
Table 115. MilliporeSigma PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 116. MilliporeSigma PECAM-1 Antibody Product
Table 117. MilliporeSigma Recent Development
Table 118. Abcam Company Information
Table 119. Abcam Introduction and Business Overview
Table 120. Abcam PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 121. Abcam PECAM-1 Antibody Product
Table 122. Abcam Recent Development
Table 123. BioLegend Company Information
Table 124. BioLegend Introduction and Business Overview
Table 125. BioLegend PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 126. BioLegend PECAM-1 Antibody Product
Table 127. BioLegend Recent Development
Table 128. Novus Biologicals Company Information
Table 129. Novus Biologicals Introduction and Business Overview
Table 130. Novus Biologicals PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 131. Novus Biologicals PECAM-1 Antibody Product
Table 132. Novus Biologicals Recent Development
Table 133. Dianova Company Information
Table 134. Dianova Introduction and Business Overview
Table 135. Dianova PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 136. Dianova PECAM-1 Antibody Product
Table 137. Dianova Recent Development
Table 138. Santa Cruz Biotechnology Company Information
Table 139. Santa Cruz Biotechnology Introduction and Business Overview
Table 140. Santa Cruz Biotechnology PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 141. Santa Cruz Biotechnology PECAM-1 Antibody Product
Table 142. Santa Cruz Biotechnology Recent Development
Table 143. Proteintech Group Company Information
Table 144. Proteintech Group Introduction and Business Overview
Table 145. Proteintech Group PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 146. Proteintech Group PECAM-1 Antibody Product
Table 147. Proteintech Group Recent Development
Table 148. R&D Systems Company Information
Table 149. R&D Systems Introduction and Business Overview
Table 150. R&D Systems PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 151. R&D Systems PECAM-1 Antibody Product
Table 152. R&D Systems Recent Development
Table 153. Miltenyi Biotec Company Information
Table 154. Miltenyi Biotec Introduction and Business Overview
Table 155. Miltenyi Biotec PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 156. Miltenyi Biotec PECAM-1 Antibody Product
Table 157. Miltenyi Biotec Recent Development
Table 158. Bio-Rad Company Information
Table 159. Bio-Rad Introduction and Business Overview
Table 160. Bio-Rad PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 161. Bio-Rad PECAM-1 Antibody Product
Table 162. Bio-Rad Recent Development
Table 163. LifeSpan Biosciences Company Information
Table 164. LifeSpan Biosciences Introduction and Business Overview
Table 165. LifeSpan Biosciences PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 166. LifeSpan Biosciences PECAM-1 Antibody Product
Table 167. LifeSpan Biosciences Recent Development
Table 168. Abnova Company Information
Table 169. Abnova Introduction and Business Overview
Table 170. Abnova PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 171. Abnova PECAM-1 Antibody Product
Table 172. Abnova Recent Development
Table 173. OriGene Company Information
Table 174. OriGene Introduction and Business Overview
Table 175. OriGene PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 176. OriGene PECAM-1 Antibody Product
Table 177. OriGene Recent Development
Table 178. SICGEN Company Information
Table 179. SICGEN Introduction and Business Overview
Table 180. SICGEN PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 181. SICGEN PECAM-1 Antibody Product
Table 182. SICGEN Recent Development
Table 183. YO Proteins Company Information
Table 184. YO Proteins Introduction and Business Overview
Table 185. YO Proteins PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 186. YO Proteins PECAM-1 Antibody Product
Table 187. YO Proteins Recent Development
Table 188. Enzo Life Sciences Company Information
Table 189. Enzo Life Sciences Introduction and Business Overview
Table 190. Enzo Life Sciences PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 191. Enzo Life Sciences PECAM-1 Antibody Product
Table 192. Enzo Life Sciences Recent Development
Table 193. Boster Company Information
Table 194. Boster Introduction and Business Overview
Table 195. Boster PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 196. Boster PECAM-1 Antibody Product
Table 197. Boster Recent Development
Table 198. Abeomics Company Information
Table 199. Abeomics Introduction and Business Overview
Table 200. Abeomics PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 201. Abeomics PECAM-1 Antibody Product
Table 202. Abeomics Recent Development
Table 203. Rockland Immunochemicals Company Information
Table 204. Rockland Immunochemicals Introduction and Business Overview
Table 205. Rockland Immunochemicals PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 206. Rockland Immunochemicals PECAM-1 Antibody Product
Table 207. Rockland Immunochemicals Recent Development
Table 208. Bon Opus Biosciences Company Information
Table 209. Bon Opus Biosciences Introduction and Business Overview
Table 210. Bon Opus Biosciences PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 211. Bon Opus Biosciences PECAM-1 Antibody Product
Table 212. Bon Opus Biosciences Recent Development
Table 213. Creative Biomart Company Information
Table 214. Creative Biomart Introduction and Business Overview
Table 215. Creative Biomart PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 216. Creative Biomart PECAM-1 Antibody Product
Table 217. Creative Biomart Recent Development
Table 218. US Biological Company Information
Table 219. US Biological Introduction and Business Overview
Table 220. US Biological PECAM-1 Antibody Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 221. US Biological PECAM-1 Antibody Product
Table 222. US Biological Recent Development
Table 223. Key Raw Materials Lists
Table 224. Raw Materials Key Suppliers Lists
Table 225. PECAM-1 Antibody Market Trends
Table 226. PECAM-1 Antibody Market Drivers
Table 227. PECAM-1 Antibody Market Challenges
Table 228. PECAM-1 Antibody Market Restraints
Table 229. PECAM-1 Antibody Distributors List
Table 230. PECAM-1 Antibody Downstream Customers
Table 231. Research Programs/Design for This Report
Table 232. Key Data Information from Secondary Sources
Table 233. Key Data Information from Primary Sources
List of Figures
Figure 1. PECAM-1 Antibody Product Picture
Figure 2. Global PECAM-1 Antibody Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global PECAM-1 Antibody Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global PECAM-1 Antibody Sales Status and Outlook (2018-2034) & (Kg)
Figure 5. Product Picture of Mouse
Figure 6. Global Mouse Sales YoY Growth (2018-2034) & (Kg)
Figure 7. Product Picture of Rabbit
Figure 8. Global Rabbit Sales YoY Growth (2018-2034) & (Kg)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (Kg)
Figure 11. Global PECAM-1 Antibody Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global PECAM-1 Antibody Sales Market Share by Type in 2022 & 2034
Figure 13. North America PECAM-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 14. North America PECAM-1 Antibody Sales Market Share in Value by Type in 2022
Figure 15. Europe PECAM-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Europe PECAM-1 Antibody Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific PECAM-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific PECAM-1 Antibody Sales Market Share in Value by Type in 2022
Figure 19. Latin America PECAM-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Latin America PECAM-1 Antibody Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa PECAM-1 Antibody Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa PECAM-1 Antibody Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by PECAM-1 Antibody Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by PECAM-1 Antibody Revenue in 2022
Figure 25. PECAM-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Laboratory
Figure 27. Global Laboratory Sales YoY Growth (2018-2034) & (Kg)
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (Kg)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (Kg)
Figure 32. Global PECAM-1 Antibody Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global PECAM-1 Antibody Sales Market Share by Application in 2022 & 2034
Figure 34. North America PECAM-1 Antibody Sales Market Share in Volume by Application in 2022
Figure 35. North America PECAM-1 Antibody Sales Market Share in Value by Application in 2022
Figure 36. Europe PECAM-1 Antibody Sales Market Share in Volume by Application in 2022
Figure 37. Europe PECAM-1 Antibody Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific PECAM-1 Antibody Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific PECAM-1 Antibody Sales Market Share in Value by Application in 2022
Figure 40. Latin America PECAM-1 Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Latin America PECAM-1 Antibody Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa PECAM-1 Antibody Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. PECAM-1 Antibody Manufacturing Cost Structure
Figure 45. PECAM-1 Antibody Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed